Program Description
The pharmaceutical supply chain is increasingly complex, and the ongoing risk of counterfeit products entering the legitimate supply chain poses significant threats to public health and safety. This article focuses on the critical importance of the Drug Supply Chain Security Act (DSCSA) in safeguarding the integrity of prescription medications in the United States. It explores the key roles of pharmacists as key trading partners under the DSCSA and their essential responsibilities in ensuring drug supply chain security. The article will cover topics such as transaction data requirements, verification processes for suspect and illegitimate products, and national standards for licensure of wholesale distributors and third-party logistics providers. Additionally, pharmacists will gain insight into available resources to support DSCSA implementation in their practice.
Target audience: Ambulatory Care Pharmacist, Community Pharmacist, Health System Pharmacist, Oncology Pharmacist, Specialty Pharmacist
Type of activity: Knowledge
Release date: July 18, 2025
Expiration date: July 18, 2026
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Recognize the risks counterfeit products create to the security of the drug supply chain and public health
- Identify the key elements and goals of the Drug Supply Chain Security Act (DSCSA)
- Review policies and procedures to ensure compliance with the DSCSA
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here